Form 4 for ELUT ELUTIA INC.
Accepted 2023-09-21 00:00:00 ET · period of report 2023-09-21 · accession 0001415889-23-013473 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-21 | 2023-09-21 | ELUT | Ferguson Matthew | CFO | A - Grant | — | +70.1K | 120.5K | +139% | — |
| D | 2023-09-21 | 2023-09-21 | ELUT | Ferguson Matthew | CFO | A - Grant | — | +105.1K | 105.1K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-09-21 | A | A | 70,053 | — | 120,519 | D | — | — | (F1) The reported securities are included within the 70,053 Units purchased by the reporting person for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock and one warrant to purchase one and one-half shares of Class A Common Stock. (F2) Includes 901 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. |
| 2 | Derivative | Warrants (rights to buy) | 2023-09-21 | A | A | 105,080 | — | 105,080 | D | $1.43 · 2023-09-21 to — | 105,080 Class A Common Stock | (F1) The reported securities are included within the 70,053 Units purchased by the reporting person for $1.4275 per Unit. Each Unit consists of one share of Class A Common Stock and one warrant to purchase one and one-half shares of Class A Common Stock. (F3) The warrant expires upon the earlier of (a) 30 trading days after the clearance by the U.S. Food & Drug Administration of the issuer's CanGarooRM antibiotic-eluting biologic envelope or (b) September 21, 2028. |